WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: 125452
CAS#: 1310349-35-9 (HCl)
Description: RO5508887, also known as RG-7129, is a potent BACE inhibitor with IC50 of 30 nM for BACE1, equally potent against BACE2 (IC50=40 nM).
Hodoodo Cat#: 125452
Name: RO-5508887 HCl
CAS#: 1310349-35-9 (HCl)
Chemical Formula: C18H15ClF3N5O2
Exact Mass: 425.09
Molecular Weight: 425.800
Elemental Analysis: C, 50.77; H, 3.55; Cl, 8.33; F, 13.39; N, 16.45; O, 7.51
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Related CAS #: 1310347-50-2 (free base) 1310349-35-9 (HCl)
Synonym: 8PU77BD4DA; RO-5508887 hydrochloride; UNII-8PU77BD4DA; 310349-35-9
IUPAC/Chemical Name: (R)-N-(3-(2-amino-5,5-difluoro-4-methyl-5,6-dihydro-4H-1,3-oxazin-4-yl)-4-fluorophenyl)-5-cyanopicolinamide hydrochloride
InChi Key: CNXVOHMMAKBONG-UNTBIKODSA-N
InChi Code: InChI=1S/C18H14F3N5O2.ClH/c1-17(18(20,21)9-28-16(23)26-17)12-6-11(3-4-13(12)19)25-15(27)14-5-2-10(7-22)8-24-14;/h2-6,8H,9H2,1H3,(H2,23,26)(H,25,27);1H/t17-;/m1./s1
SMILES Code: Cl.C[C@@]1(N=C(N)OCC1(F)F)C2=CC(NC(=O)C3=NC=C(C=C3)C#N)=CC=C2F
Appearance: To be determined
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 425.80 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Jacobsen H, Ozmen L, Caruso A, Narquizian R, Hilpert H, Jacobsen B, Terwel D,
Tanghe A, Bohrmann B. Combined treatment with a BACE inhibitor and anti-Aβ
antibody gantenerumab enhances amyloid reduction in APPLondon mice. J Neurosci.
2014 Aug 27;34(35):11621-30. doi: 10.1523/JNEUROSCI.1405-14.2014. PubMed PMID:
25164658; PubMed Central PMCID: PMC4145168.